<?xml version="1.0" encoding="UTF-8"?>
<ref id="B41-viruses-12-00177">
 <label>41.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mechlia</surname>
    <given-names>M.B.</given-names>
   </name>
   <name>
    <surname>Belaid</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Castel</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Jallet</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Mansfield</surname>
    <given-names>K.L.</given-names>
   </name>
   <name>
    <surname>Fooks</surname>
    <given-names>A.R.</given-names>
   </name>
   <name>
    <surname>Hani</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Tordo</surname>
    <given-names>N.</given-names>
   </name>
  </person-group>
  <article-title>Dermaseptins as potential antirabies compounds</article-title>
  <source>Vaccine</source>
  <year>2019</year>
  <volume>37</volume>
  <fpage>4694</fpage>
  <lpage>4700</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2018.01.066</pub-id>
  <pub-id pub-id-type="pmid">29439871</pub-id>
 </element-citation>
</ref>
